Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Burgess, MA; Bolejack, V; Van Tine, BA; Schuetze, S; Hu, J; D'Angelo, SP; Attia, S; Priebat, DA; Okuno, SH; Riedel, RF; Davis, LE; Movva, S; Reed, DR; Butterfield, LH; Roszik, J; Reinke, DK; Baker, LH; Maki, RG; Patel, S; Tawbi, HA-H

Published Date

  • May 20, 2017

Published In

Volume / Issue

  • 35 / 15_suppl

Start / End Page

  • 11008 - 11008

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2017.35.15_suppl.11008